Oxidative stress: The lead or supporting actor in the pathogenesis of diabetic complications

Journal of the American Society of Nephrology

Volumn 14, Issue SUPPL. 3, 2003, Pages

  Kuroki, Tatsuya ^a   Isshiki, Keiji ^a   King, George L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACETYL COENZYME A; ALDEHYDE REDUCTASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CYTOKINE; DIACYLGLYCEROL; FATTY ACID; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; ISOPROSTANE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOCTIC ACID;

ADIPOSE TISSUE; ANIMAL MODEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MICROVASCULATURE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0042867416     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Duckworth WC: Hyperglycemia and cardiovascular disease. Curr Atheroscler Rep 3: 383-391, 2001
2. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996
3. Egan BM, Greene EL, Goodfriend TL: Insulin resistance and cardiovascular disease. Am J Hypertens 14: 116S-125S, 2001
4. Ginsberg HN: Insulin resistance and cardiovascular disease. J Clin Invest 106: 453-458, 2000
5. Khamaisi M, Kavel O, Rosenstock M, Porat M, Yuli M, Kaiser N, Rudich A: Effect of inhibition of glutathione synthesis on insulin action: In vivo and in vitro studies using buthionine sulfoximine. Biochem J 349: 579-586, 2000
6. Maechler P, Jornot L, Wollheim CB: Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells. J Biol Chem 274: 27905-27913, 1999
7. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001
8. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8, 2003
9. Boden G, Shulman GI: Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32[Suppl 3]: 14-23, 2002
10. Itani SI, Ruderman NB, Schmieder F, Boden G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-alpha. Diabetes 51: 2005-2011, 2002
11. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC: Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: Results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25: 1919-1927, 2002
12. Kawamura M, Heinecke JW, Chait A: Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 94: 771-778, 1994
13. Zou MH, Shi C, Cohen RA: Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002
14. Shinomiya K, Fukunaga M, Kiyomoto H, Mizushige K, Tsuji T, Noma T, Ohmori K, Kohno M, Senda S: A role of oxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats. Hypertens Res 25: 91-98, 2002
15. Mezzetti A, Cipollone F, Cuccurullo F: Oxidative stress and cardiovascular complications in diabetes: Isoprostanes as new markers on an old paradigm. Cardiovasc Res 47: 475-488, 2000
16. Kakimoto M, Inoguchi T, Sonta T, Yu HY, Imamura M, Etoh T, Hashimoto T, Nawata H: Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 51: 1588-1595, 2002
17. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417: 150-152, 1997
18. Ruiz C, Alegria A, Barbera R, Farre R, Lagarda MJ: Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 59: 99-105, 1999
19. Campoy C, Baena RM, Blanca E, Lopez-Sabater C, Fernandez-Garcia JM, Miranda MT, Molina-Font JA, Bayes R: Effects of metabolic control on vitamin E nutritional status in children with type 1 diabetes mellitus. Clin Nutr 22: 81-86, 2003
20. Will JC, Ford ES, Bowman BA: Serum vitamin C concentrations and diabetes: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 70: 49-52, 1999
21. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48: 1-9, 1999
22. Dunlop M: Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77: S3-S12, 2000
23. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37: 264-269, 1994
24. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000
25. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev 23: 599-622, 2002
26. Douillet C, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M: Effect of selenium and vitamin E supplementation on lipid abnormalities in plasma, aorta, and adipose tissue of Zucker rats. Biol Trace Elem Res 65: 221-236, 1998
27. Paolisso G, Gambardella A, Tagliamonte MR, Saccomanno F, Salvatore T, Gualdiero P, D'Onofrio MV, Howard BV: Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? J Clin Endocrinol Metab 81: 4244-4248, 1996
28. Kowluru RA, Kennedy A: Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Investig Drugs 10: 1665-1676, 2001
29. Doi K, Sawada F, Toda G, Yamachika S, Seto S, Urata Y, Ihara Y, Sakata N, Taniguchi N, Kondo T, Yano K: Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats. Free Radic Res 34: 251-261, 2001
30. Haak E, Usadel KH, Kusterer K, Amini P, Frommeyer R, Tritschler HJ, Haak T: Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes 108: 168-174, 2000
31. Loebstein R, Lehotay DC, Luo X, Bartfay W, Tyler B, Sher GD: Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress. Diabetes Care 21: 1306-1309, 1998
32. Mooradian AD: Cardiovascular disease in type 2 diabetes mellitus: Current management guidelines. Arch Intern Med 163: 33-40, 2003
33. Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL: High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22: 1245-1251, 1999
34. Packer L, Kraemer K, Rimbach G: Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17: 888-895, 2001
35. Ruhe RC, McDonald RB: Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 20: 363S-369S; discussion 381S-383S, 2001
36. Montero A, Munger KA, Khan RZ, Valdivielso JM, Morrow JD, Guasch A, Ziyadeh FN, Badr KF: F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int 58: 1963-1972, 2000
37. Greene EL, Nelson BA, Robinson KA, Buse MG: Alpha-lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation. Metabolism 50: 1063-1069, 2001
38. Studer RK, Craven PA, DeRubertis FR: Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46: 918-925, 1997
39. Trachtman H, Futterweit S, Bienkowski RS: Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem Biophys Res Commun 191: 759-765, 1993
40. Cameron NE, Cotter MA: Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 45: 137-146, 1999
41. Abiko T, Abiko A, Clermont AC, Shoelson B, Horio N, Takahashi J, Adamis AP, King GL, Bursell SE: Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: Role of oxidants and protein kinase-c activation. Diabetes 52: 829-837, 2003
42. Koya D, Lee IK, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with dalpha-tocopherol. J Am Soc Nephrol 8: 426-435, 1997
43. Gaede P, Poulsen HE, Parving HH, Pedersen O: Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med 18: 756-760, 2001
44. Kunisaki M, Bursell SE, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269: E239-E246, 1995
45. Sakamoto W, Fujie K, Handa H, Ogihara T, Mino M: In vivo inhibition of superoxide production and protein kinase C activity in macrophages from vitamin E-treated rats. Int J Vitam Nutr Res 60: 338-342, 1990
46. Ozer NK, Azzi A: Effect of vitamin E on the development of atherosclerosis. Toxicology 148: 179-185, 2000
47. Keaney JF Jr, Simon DI, Freedman JE: Vitamin E and vascular homeostasis: Implications for atherosclerosis. FASEB J 13: 965-975, 1999
48. Sirikci O, Ozer NK, Azzi A: Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aortic smooth muscle cells. Atherosclerosis 126: 253-263, 1996
49. Boscoboinik D, Szewczyk A, Azzi A: Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch Biochem Biophys 286: 264-269, 1991
50. van Dam PS: Oxidative stress and diabetic neuropathy: Pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 18: 176-184, 2002
51. Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A: The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: Potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 50: 1464-1471, 2001
52. Venugopal SK, Devaraj S, Yang T, Jialal I: Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 51: 3049-3054, 2002
53. Beckman JA, Goldfine AB, Gordon MB, Creager MA: Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 103: 1618-1623, 2001
54. Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S: Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation. Diabetes Care 19: 1225-1228, 1996
55. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-786, 1996
56. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356: 1213-1218, 2000